Diabetes, Prediabetes, and Brain Volumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)
Open Access
- 15 September 2017
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 40 (11) , 1514-1521
Abstract
OBJECTIVE To examine the associations of prediabetes, diabetes, and diabetes severity (as assessed by HbA1c and diabetes duration) with brain volumes and vascular pathology on brain MRI and to assess whether the associations of diabetes with brain volumes are mediated by brain vascular pathology. RESEARCH DESIGN AND METHODS Cross-sectional study of 1,713 participants in the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS) (mean age 75 years, 60% female, 27% black, 30% prediabetes, and 35% diabetes) who underwent 3T brain MRI scans in 2011–2013. Participants were categorized by diabetes-HbA1c status as without diabetes (1c ≥6.5%] 1c 1c 0.05), but those with diabetes and HbA1c ≥7.0% had smaller total brain volume (β −0.20 SDs, 95% CI −0.31, −0.09), smaller regional brain volumes (including frontal, temporal, occipital, and parietal lobes; deep gray matter; Alzheimer disease signature region; and hippocampus [all P < 0.05]), and increased burden of white matter hyperintensities (WMH) (P = 0.016). Among participants with diabetes, those with HbA1c ≥7.0% had smaller total and regional brain volumes and an increased burden of WMH (all P < 0.05) compared with those with HbA1c P < 0.05) than those with a diabetes duration 0.05). CONCLUSIONS More-severe diabetes (defined by higher HbA1c and longer disease duration) but not prediabetes or less-severe diabetes was associated with smaller brain volumes and an increased burden of brain vascular pathology. No evidence was found that associations of diabetes with smaller brain volumes are mediated by brain vascular pathology, suggesting that other mechanisms may be responsible for these associations.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (HH-SN-268201100005C, HH-SN-268201100006C, HH-SN-268201100007C, HH-SN-268201100008C, HH-SN-268201100009C, HH-SN-268201100010C, HH-SN-268201100011C, HH-SN-268201100012C, U01-HL-096812, U01-HL-096814, U01-HL-096899, U01-HL-096902, U01-HL-096917)
- National Institute of Neurological Disorders and Stoke (R25-NS-065729)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24-DK-106414, R01-DK-089174)
This publication has 41 references indexed in Scilit:
- Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationThe Lancet Neurology, 2013
- Macro- and Microstructural Magnetic Resonance Imaging Indices Associated With Diabetes Among Community-Dwelling Older AdultsDiabetes Care, 2013
- Risk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) StudyNeurology, 2012
- Vascular risk factors and longitudinal changes on brain MRINeurology, 2011
- Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adultsNeurology, 2011
- Glycemic Status and Brain Injury in Older IndividualsDiabetes Care, 2009
- Risk of dementia in MCINeurology, 2009
- Brain Imaging in Patients With DiabetesDiabetes Care, 2006
- Brain Aging in Very Old Men With Type 2 DiabetesDiabetes Care, 2006
- Whole Brain SegmentationNeuron, 2002